Question 1

What is Cortexa?

Accepted Answer

Cortexa is a Entity.

Question 2

How often does Cortexa appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Cortexa first tracked by Ergen?

Accepted Answer

First tracked on Jul 06, 2026.

Question 4

When was Cortexa last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is Cortexa's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Cortexa in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Cortexa?

Accepted Answer

PharmAla ALA-002 Manufacturing, Patent, Australia (Jul 06, 2026, 7 articles).

Question 8

How did the "PharmAla ALA-002 Manufacturing, Patent, Australia" event impact Cortexa?

Accepted Answer

Cortexa, a joint venture between PharmAla Biotech Holdings and Vitura Health, exercised its option to commercialize Non-racemic MDMA intellectual property for the Australian market, where it holds a dominant position.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.